OTC · Financial Statements
CEN Biotech, Inc. (CENBF) Financial Statements
$0.00
OTC: CENBF
Market Cap $6526
Overview Financials Dividend CEN Biotech, Inc. most recently reported annual revenue of $1.0M, net profit of $-19.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2017 2018 2019 2020 2021 Revenue $0 — — $0 $1.0M Operating Profit $-12.0M $-4.0M $-3.0M $-3.0M $-19.0M Net Profit $-14.0M $-8.0M $-6.0M $14.0M $-19.0M EPS $-0.56 $-0.30 $-0.21 $0.45 $-0.45 Op Margin — — — — -3037.0%
Balance Sheet (USD)
Metric 2017 2018 2019 2020 2021 Total Assets $9.0M $7.0M $7.0M $6.0M $8.0M Total Liabilities $28.0M $29.0M $33.0M $16.0M $10.0M Cash $0 $0 $0 $0 $0 Borrowings $10.0M $10.0M $10.0M $1.0M $2.0M
Cash Flow (USD)
Metric 2017 2018 2019 2020 2021 Operating Cash Flow $-2.0M $-2.0M $-1.0M $0 $0 Investing Cash Flow $-1.0M $0 $0 $0 $0 Financing Cash Flow $3.0M $2.0M $1.0M $0 $1.0M Net Cash Flow $0 $0 $0 $0 $0 Free Cash Flow $-2.0M $-2.0M $-1.0M $0 $0
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -6.66 FCF Yield -7125.91% Quick Ratio 0.03 Interest Coverage -5.00 Return 1Y 0.00% Return 3Y -99.36% Return 5Y -99.98%
Screens featuring this stock